Eris lifesciences initiating coverage
WebOct 16, 2024 · Citi Research initiated coverage on Eris Lifesciences Ltd. with a ‘Buy’ rating on the back of a strong balance sheet and healthy return ratios. Citi sees margin expansion of 500 basis points in Eris Lifesciences; Initiates coverage. WebDec 5, 2024 · Read latest news and live updates on Eris-lifesciences including breaking news on Eris-lifesciences, Eris-lifesciences photos, Eris-lifesciences videos and many more at cnbctv18.com. ... Motilal Oswal bullish on Eris Lifesciences; initiates coverage with buy. healthcare Dec 6, 2024 6:03 PM IST. Eris Lifesciences expects 10% market …
Eris lifesciences initiating coverage
Did you know?
WebApr 9, 2024 · Rankings Coverage. Screeners Stock Screener Home. Investment Themes. The Vegan Market. Fintechs. Water. The SPAC. Strategic Metals. Financial Data. ... Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s … WebJan 3, 2024 · We initiate coverage on Eris Lifesciences (ERIS) with a Buy rating and a target price of Rs 870. In just 14 years (founded in CY07), ERIS has built a pure-play …
WebEris is headquartered in Ahmedabad, Gujarat, India. Gain a 360-degree view of Eris Lifesciences Ltd and make more informed decisions for your business Contact Us. … WebNov 28, 2024 · The research house believes existing business should grow at 15 percent CAGR and entry into new areas should boost growth.
WebEris LifesciencesInitiating Coverage 27 December 2024 3 The Pharma Brand Master Mix of Chronic portfolio, rising coverage, and better operating leverage to drive … WebINITIATING COVERAGE BOB Capital Markets Ltd is a wholly owned subsidiary of Bank of Baroda Important disclosures, including any required research …
WebDec 28, 2024 · Motilal Oswal Financial Services (MOFSL) has initiated coverage on Eris Lifesciences with a buy and a target price of Rs 870. Recommended Articles View All Karnataka Election 2024: Why these Lingayat and Vokkaliga-dominated seats are crucial …
WebERIS shortcut browser chromeWebOperating Status Active. Last Funding Type Private Equity. Legal Name Eris Lifesciences Limited. Stock Symbol NSE:ERIS. Company Type For Profit. Contact Email [email protected]. Phone Number +917930451111. Eris Lifesciences is a domestic pharmaceutical company in India that focuses on the chronic and lifestyle diseases segment. The Company has ... shortcut browser search fieldWebEris Lifesciences Ltd is the only publicly listed Indian pharmaceutical company with a pure-play domestic branded formulations business model. Ranked # 21 in the IPM, … sandy school district officeWebAug 23, 2016 · Discussions have been initiated for Eris Lifesciences's IPO, which could be of Rs600-800 crore in size. ... Swaraj Singh Dhanjal is responsible for Mint’s corporate news coverage. For the past ... sandy school district oregonWebApr 10, 2024 · Eris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, … shortcut browser startenWebDec 5, 2024 · Read latest news and live updates on Eris-lifesciences including breaking news on Eris-lifesciences, Eris-lifesciences photos, Eris-lifesciences videos and many … shortcut browser minimierenWebDec 28, 2024 · The domestic research firm has initiated coverage on Eris Lifesciences with a ‘buy’ rating and a target price of Rs 870 per share, an upside of 20 percent from … shortcut brush tool photoshop